Compare SoFi Technologies Inc (SOFI) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SoFi Technologies Inc vs GeneDx Holdings Corp — how do they compare? SoFi Technologies Inc trades at $15.8 (market cap $20.16B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: SoFi Technologies Inc is far larger — about 10× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SoFi Technologies Inc for 60 Days and GeneDx Holdings Corp for 19 Days on average.
| SOFI | WGS | |
|---|---|---|
Market Cap | $20.16B | $2.02B |
Volume | 49,646,331 | 734,640 |
Sector | Financials | Health |
52-Week High | $32.21 | $167.51 |
52-Week Low | $15.15 | $34.51 |
Typical Hold Time | 60 Days | 19 Days |
Enterprise Value | $20.30B | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SOFI Technologies trades at $15.61, down 0.32% with a bearish technical outlook. The stock shows strong fundamental progress with revenue growth from $1.6B in 2022 to $3.6B in 2025 and consistent earnings beats. Analyst consensus is mixed with a $21.58 price target representing 38% upside potential. Recent news highlights stablecoin initiatives and record loan originations despite stock underperformance.
SOFI presents a growth opportunity with expanding revenue and profitability, though execution risks and rate sensitivity remain concerns. The valuation at 31.86 P/E appears reasonable for growth trajectory, but negative operating cash flows and competitive pressures warrant caution. Near-term catalyst includes Q3 earnings on October 27, 2026.
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
